Stay updated with breaking news from Gina Cestari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer
PRINCETON, N.J., Jan. 16, 2024 -- PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease...
First study of patients with metastatic prostate cancer to evaluate standard-of-care chemotherapy combined with an antibody drug conjugate .Decrease in prostate specific antigen levels was seen in...
PHILADELPHIA, Sept. 27, 2023 -- Context Therapeutics Inc. , a biopharmaceutical company advancing medicines for solid tumors, today announced a poster regarding the Company’s preclinical asset,...
PDS0202 (Infectimune® + COBRA influenza antigens) vaccination also prevented illness/weight loss Vaccine protected against replication of the virus in the...